Related Experiment Videos

Mitochondrial DNA and RNA processing in MELAS

P Kaufmann1, Y Koga, S Shanske

  • 1H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Disorders, New York, NY, USA.

Annals of Neurology
|August 1, 1996
PubMed

Insights

Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) involves increased mitochondrial DNA and altered RNA metabolism. These changes, observed in patient tissues, suggest a key role in the disorder's pathogenesis.

Area of Science:

  • Genetics
  • Mitochondrial Biology
  • Neurology

Background:

  • Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS) is a maternally inherited disorder.
  • It is typically linked to a specific point mutation (m.3243A>G) in the mitochondrial DNA (mtDNA) tRNA Leu(UUR) gene.

Purpose of the Study:

  • To investigate the pathogenesis of MELAS by analyzing tissues from patients with the 3,243 mtDNA mutation.
  • To examine mitochondrial DNA and RNA alterations in various tissues affected by MELAS.

Main Methods:

  • Southern blot analysis to assess the ratio of mitochondrial DNA (mtDNA) to nuclear DNA.
  • Northern blot analysis to quantify steady-state levels of specific polycistronic transcripts.

Main Results:

  • Increased mtDNA to nuclear DNA ratio observed in most tissues from MELAS patients, indicating widespread mitochondrial proliferation.
  • Elevated levels of RNA 19, a transcript encompassing 16S rRNA, tRNA Leu(UUR), and ND1 genes, found in heart, kidney, and muscle tissues.
  • Mitochondrial proliferation is not limited to ragged-red fibers in muscle tissue.

Conclusions:

  • Altered mitochondrial nucleic acid metabolism, including increased mtDNA and specific transcript levels, plays a significant role in MELAS pathogenesis.
  • The findings support the hypothesis that disruptions in mitochondrial gene expression contribute to the multi-systemic manifestations of MELAS.

Related Concept Videos